Article info

Colchicine prophylaxis is associated with fewer gout flares after COVID-19 vaccination

Authors

  • Jie Lu Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, the Affiliated Hospital of Qingdao University, Qingdao, China Shandong Provincial Clinical Research Center for Immune Diseases and Gout, the Affiliated Hospital of Qingdao University, Qingdao, China Institute of Metabolic Diseases, Qingdao University, Qingdao, China Department of Endocrinology and Metabolism, the Affiliated Hospital of Qingdao University, Qingdao, China PubMed articlesGoogle scholar articles
  • Yuwei He Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, the Affiliated Hospital of Qingdao University, Qingdao, China PubMed articlesGoogle scholar articles
  • Robert Terkeltaub VA San Diego VA Healthcare Center, University of California San Diego, San Diego, California, USA PubMed articlesGoogle scholar articles
  • Mingshu Sun Department of Rheumatology, the Affiliated Hospital of Qingdao University, Qingdao, China PubMed articlesGoogle scholar articles
  • Zijing Ran Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, the Affiliated Hospital of Qingdao University, Qingdao, China PubMed articlesGoogle scholar articles
  • Xinmiao Xu Department of Endocrinology and Metabolism, Yantai Yeda Hospital, Yantai, China PubMed articlesGoogle scholar articles
  • Can Wang Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, the Affiliated Hospital of Qingdao University, Qingdao, China PubMed articlesGoogle scholar articles
  • Xinde Li Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, the Affiliated Hospital of Qingdao University, Qingdao, China PubMed articlesGoogle scholar articles
  • Shuhui Hu Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, the Affiliated Hospital of Qingdao University, Qingdao, China PubMed articlesGoogle scholar articles
  • Xiaomei Xue Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, the Affiliated Hospital of Qingdao University, Qingdao, China PubMed articlesGoogle scholar articles
  • Fei Yan Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, the Affiliated Hospital of Qingdao University, Qingdao, China PubMed articlesGoogle scholar articles
  • Hui Zhang Institute of Metabolic Diseases, Qingdao University, Qingdao, China PubMed articlesGoogle scholar articles
  • Huiyong Yin CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences (CAS), Shanghai, China School of Life Science and Technology, ShanghaiTech University, Shanghai, China University of Chinese Academy of Sciences, CAS, Beijing, China PubMed articlesGoogle scholar articles
  • Yongyong Shi Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China Institute of Biomedical Sciences, Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao University, Qingdao, China PubMed articlesGoogle scholar articles
  • Nicola Dalbeth Department of Medicine, University of Auckland, Auckland, New Zealand PubMed articlesGoogle scholar articles
  • Changgui Li Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, the Affiliated Hospital of Qingdao University, Qingdao, China Shandong Provincial Clinical Research Center for Immune Diseases and Gout, the Affiliated Hospital of Qingdao University, Qingdao, China Institute of Metabolic Diseases, Qingdao University, Qingdao, China Department of Endocrinology and Metabolism, the Affiliated Hospital of Qingdao University, Qingdao, China PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Changgui Li, The Affiliated Hospital of Qingdao University, Qingdao, China; lichanggui{at}medmail.com.cn; Professor Nicola Dalbeth; n.dalbeth{at}auckland.ac.nz
View Full Text

Citation

Lu J, He Y, Terkeltaub R, et al
Colchicine prophylaxis is associated with fewer gout flares after COVID-19 vaccination

Publication history

  • Received January 21, 2022
  • Accepted February 28, 2022
  • First published March 11, 2022.
Online issue publication 
July 12, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.